• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAM家族蛋白酶介导的膜蛋白脱落

Shedding of membrane proteins by ADAM family proteases.

作者信息

Moss Marcia L, Lambert Millard H

机构信息

Cognosci Inc., 2 Davis Drive, P.O. Box 12076, Research Triangle Park, NC 27709, USA.

出版信息

Essays Biochem. 2002;38:141-53. doi: 10.1042/bse0380141.

DOI:10.1042/bse0380141
PMID:12463167
Abstract

Many membrane-bound proteins undergo proteolytic release from the membrane, a process known as 'shedding'. Some of the processing events are carried out by enzymes of the ADAM (a disintegrin and metalloproteinase) family, which are also membrane bound. One of the most well known ADAM family members is TACE (tumour necrosis factor-alpha-converting enzyme. TACE was the first ADAM family member to have a known physiological substrate, namely, precursor tumour necrosis factor-alpha. Inhibitors of TACE block the release of the soluble form of this inflammatory cytokine, and are currently being studied in drug discovery projects for the treatment of arthritis. Since the discovery of TACE, physiological substrates for other ADAMs have been determined. This review focuses on the shedding events carried out by TACE and other ADAM family proteinases.

摘要

许多膜结合蛋白会经历从膜上的蛋白水解释放过程,这一过程被称为“脱落”。其中一些加工事件是由ADAM(一种解整合素和金属蛋白酶)家族的酶来完成的,这些酶同样也是膜结合的。ADAM家族最著名的成员之一是TACE(肿瘤坏死因子-α转化酶)。TACE是第一个有已知生理底物的ADAM家族成员,即肿瘤坏死因子-α前体。TACE抑制剂可阻断这种炎性细胞因子可溶性形式的释放,目前正在药物研发项目中进行研究,用于治疗关节炎。自TACE被发现以来,其他ADAM的生理底物也已确定。本综述重点关注TACE和其他ADAM家族蛋白酶所引发的脱落事件。

相似文献

1
Shedding of membrane proteins by ADAM family proteases.ADAM家族蛋白酶介导的膜蛋白脱落
Essays Biochem. 2002;38:141-53. doi: 10.1042/bse0380141.
2
Tumor necrosis factor-alpha converting enzyme.肿瘤坏死因子-α转化酶
Int J Biochem Cell Biol. 2002 Jan;34(1):1-5. doi: 10.1016/s1357-2725(01)00097-8.
3
Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE).解整合素金属蛋白酶。一个包含肿瘤坏死因子-α转换酶(TACE)的金属锌蛋白酶家族。
Ann N Y Acad Sci. 1999 Jun 30;878:442-52. doi: 10.1111/j.1749-6632.1999.tb07701.x.
4
Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.肿瘤坏死因子-α转化酶结构域结构的功能分析
J Biol Chem. 2000 May 12;275(19):14608-14. doi: 10.1074/jbc.275.19.14608.
5
TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.表皮生长因子受体(EGFR)配体的经动脉化疗栓塞术(TACE)/肿瘤坏死因子α转换酶(ADAM17)加工表明其作为一种生理转化酶的作用。
Ann N Y Acad Sci. 2003 May;995:22-38. doi: 10.1111/j.1749-6632.2003.tb03207.x.
6
Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form.肿瘤坏死因子由膜结合型肿瘤坏死因子α转换酶进行加工处理,而非其截短的可溶性形式。
Eur J Biochem. 2001 Apr;268(7):2074-82. doi: 10.1046/j.1432-1327.2001.02085.x.
7
The importance of shedding of membrane proteins for cytokine biology.膜蛋白脱落对细胞因子生物学的重要性。
Eur Cytokine Netw. 2000 Mar;11(1):27-38.
8
TACE and other ADAM proteases as targets for drug discovery.以TACE和其他ADAM蛋白酶作为药物研发的靶点。
Drug Discov Today. 2001 Apr 1;6(8):417-426. doi: 10.1016/s1359-6446(01)01738-x.
9
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.一种从细胞中释放肿瘤坏死因子-α的金属蛋白酶解整合素。
Nature. 1997 Feb 20;385(6618):729-33. doi: 10.1038/385729a0.
10
Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme.淀粉样前体蛋白胞外结构域的组成性脱落受肿瘤坏死因子-α转换酶上调。
Biochem J. 2001 Aug 1;357(Pt 3):787-94. doi: 10.1042/0264-6021:3570787.

引用本文的文献

1
ADAM Metallopeptidase domain 19 promotes skin fibrosis in systemic sclerosis via neuregulin-1.ADAM金属蛋白酶结构域19通过神经调节蛋白-1促进系统性硬化症中的皮肤纤维化。
Mol Med. 2024 Dec 23;30(1):269. doi: 10.1186/s10020-024-01047-8.
2
Identification of circulating T-cell immunoglobulin and mucin domain 4 as a potential biomarker for coronary heart disease.循环T细胞免疫球蛋白和粘蛋白结构域4作为冠心病潜在生物标志物的鉴定。
MedComm (2020). 2023 Jul 8;4(4):e320. doi: 10.1002/mco2.320. eCollection 2023 Aug.
3
ADAMs family in kidney physiology and pathology.
ADAMs 家族在肾脏生理学和病理学中的作用。
EBioMedicine. 2021 Oct;72:103628. doi: 10.1016/j.ebiom.2021.103628. Epub 2021 Oct 12.
4
Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility.ACE2 在妊娠中的作用及其对 COVID-19 易感性的潜在影响。
Clin Sci (Lond). 2021 Aug 13;135(15):1805-1824. doi: 10.1042/CS20210284.
5
ADAM10 promotes cell growth, migration, and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p.ADAM10通过调节E-钙黏蛋白/β-连环蛋白信号通路促进骨肉瘤细胞的生长、迁移和侵袭,并受miR-122-5p调控。
Cancer Cell Int. 2020 Mar 30;20:99. doi: 10.1186/s12935-020-01174-2. eCollection 2020.
6
Enhancer RNA and NFκB-dependent P300 regulation of ADAMDEC1.增强子 RNA 和 NFκB 依赖性 P300 对 ADAMDEC1 的调控。
Mol Immunol. 2018 Nov;103:312-321. doi: 10.1016/j.molimm.2018.09.019. Epub 2018 Oct 20.
7
Therapeutic potential of targeting the Eph/ephrin signaling complex.靶向 Eph/ephrin 信号复合物的治疗潜力。
Int J Biochem Cell Biol. 2018 Dec;105:123-133. doi: 10.1016/j.biocel.2018.10.006. Epub 2018 Oct 19.
8
Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma.多发性骨髓瘤患者治疗前后血栓形成相关生物标志物的评估
J Blood Med. 2018 Jan 19;9:1-7. doi: 10.2147/JBM.S147743. eCollection 2018.
9
MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes.微小RNA-126过表达可挽救糖尿病诱导的凋亡心肌细胞吞噬功能障碍。
Sci Rep. 2016 Nov 9;6:36207. doi: 10.1038/srep36207.
10
The role of proteases in regulating Eph/ephrin signaling.蛋白酶在调节 Eph/ephrin 信号中的作用。
Cell Adh Migr. 2014;8(4):294-307. doi: 10.4161/19336918.2014.970026.